We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Core Site-Moiety Maps Reveal Inhibitors and Binding Mechanisms of Orthologous Proteins by Screening Compound Libraries

Study reveals the CoreSiMMap is useful to identify adaptive SK inhibitors and provide insight into the binding mechanisms of compounds.
News

Verona Pharma Appoints Manchester Clinical Research Facility to Carry Out Clinical Trial with RPL554

Enrollment of patients to start Q2, with results expected early Q4 2012.
News

Lipid Therapeutics Licenses European Rights to LT-02 for Ulcerative Colitis

Dr. Falk Pharma GmbH to initiate Phase III trial.
News

CiToxLAB Increases Inhalation Test Capabilities in North America and Europe

Growth in capacity and capabilities sees CiToxLAB emerge as a major player in the safety assessment of pharmaceuticals and chemicals via the inhalation route.
News

Macro-to-Micro Structural Proteomics: Native Source Proteins for High-Throughput Crystallization

In this study, researchers from University of California demonstrate the utility of native source proteins for high-throughput crystallography.
News

Motion and Flexibility in Human Cytochrome p450 Aromatase

X-ray structures of human placental aromatase do not provide accounts of movements in this work, researchers conduct normal mode analysis revealing the intrinsic fluctuations of aromatase.
News

Global Patterns of Genetic Diversity and Signals of Natural Selection for Human ADME Genes

This study is the first to systematically investigate worldwide population differentiation and potential signals of natural selection in a comprehensive list of ADME genes.
News

ACADIA Pharmaceuticals Extends Drug Discovery Collaboration with Allergan, Inc.

The collaboration is currently focused on the discovery of new therapeutics for glaucoma and other ophthalmic indications and was originally established in March 2003.
News

A High-Throughput Screen Identifies a New Natural Product with Broad-Spectrum Antibacterial Activity

Researchers from Children's Hospital, Boston report the development of a sensitive and robust but low-tech and inexpensive high-throughput metabolic screen for novel antibiotics.
News

Simcyp Limited Acquired by Certara

The acquisition makes Simcyp the third member of the Certara group alongside Tripos and Pharsight.
Advertisement